Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey

Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey

Background: The use of pegylated interferon alpha and ribavirin (PegIFN/RBV) for the retreatment of chronic hepatitis C virus (HCV) infection without a sustained virological response (SVR) prior to PegIFN/RBV treatment has resulted in low success rates. Aims: To investigate the efficacy and safet...

Full description

Bibliographic Details
Main Authors:	Orhan Yıldız, Sıla Akhan, Elif Sargın Altınok, Mustafa Kemal Çelen, Onur Ural, Nazlım Aktuğ Demir, Şua Sümer, Süda Tekin Koruk, Şükran Köse, Fatime Korkmaz, Ziya Kuruüzüm, Nazan Tuna, Serpil Taheri, Murat Sayan
Format:	Article
Language:	English
Published:	Galenos Publishing House 2015-09-01
Series:	Balkan Medical Journal
Subjects:	Chronic hepatitis C telaprevir therapy treatment-experienced
Online Access:	http://balkanmedicaljournal.org/text.php?lang=en&id=198

Similar Items

Cutaneous Eruption due to Telaprevir
by: Eduardo Mastrangelo Marinho Falcão, et al.
Published: (2015-09-01)

Telaprevir or Boceprevir for Hepatitis C treatment: a first survey of pharmacoutilization
by: Maurizio eCapuozzo, et al.
Published: (2013-09-01)

Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese
by: Choi Y, et al.
Published: (2018-04-01)

Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C
by: Nagihan İnan Gürcan, et al.
Published: (2016-12-01)

Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014-01-01)

Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir
by: Beatriz Rodríguez-Medina, et al.
Published: (2013-11-01)

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
by: Xavier Forns, et al.
Published: (2016-07-01)

Compensatory substitutions in the HCV NS3/4A protease cleavage sites are not observed in patients treated unsuccessfully with telaprevir combination treatment
by: Sullivan James C, et al.
Published: (2012-08-01)

Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
by: I G Nikitin, et al.
Published: (2012-11-01)

Telaprevir: Changing the standard of care of chronic hepatitis C
by: A K Rajani, et al.
Published: (2013-01-01)

Comparative analysis of the safety of triple therapy with telaprevir between HCV monoinfected and HIV coinfected patients
by: C. Sangrador Pelluz, et al.
Published: (2014-01-01)

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Avaliação do tratamento de hepatite C crônica, no ambulatório do Conjunto Hospitalar de Sorocaba, com o uso do Telaprevir e sua relação com as desordens tireoidianas
by: Fernando José Goés Ruiz, et al.
Published: (2016-10-01)

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
by: Torres HA, et al.
Published: (2014-07-01)

Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
by: C Kondo, et al.
Published: (2016-01-01)

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman
by: Hamid Hasson, et al.
Published: (2014-12-01)

Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients
by: Blanca Gros, et al.
Published: (2014-09-01)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
by: Amal Mahmoud, et al.
Published: (2021-09-01)

Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
by: Borba HHL, et al.
Published: (2017-01-01)

A SHORT COURSE OF TRIPLE TELAPREVIR-BASED ANTIVIRAL THERAPY: THE PRINCIPLES OF PATIENTS SELECTION
by: P. O. Bogomolov, et al.
Published: (2016-02-01)

The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort
by: Midori Kjellin, et al.
Published: (2018-01-01)

Efetividade e segurança da terapia tripla com boceprevir ou telaprevir no tratamento da hepatite C crônica genótipo 1 em pacientes atendidos em centros de referência no Brasil
by: Luciana Azevêdo Callefi
Published: (2017)

Efetividade e segurança da terapia tripla com boceprevir ou telaprevir no tratamento da hepatite C crônica genótipo 1 em pacientes atendidos em centros de referência no Brasil
by: Callefi, Luciana Azevêdo
Published: (2017)

Treatment of hepatitis C virus infection in the future
by: Tatsuo Kanda, et al.
Published: (2013-12-01)

http://www.aulamedica.es/fh/pdf/1129.pdf
by: R. López-Sepúlveda, et al.
Published: (2014-01-01)

HCV NS3 inhibitors resistance mutations in the telaprevir started Turkish patients with chronic HCV
by: M. Sayan, et al.
Published: (2014-04-01)

A Case of Tuberculosis Septic Arthritis in the Knee Joint
by: Onur Ural, et al.
Published: (2018-12-01)

Distribution and Evaluation of Vancomycin Resistant Enterococci Seen in Selcuk University Medical Faculty Hospital between 2012 and 2015
by: Ayşe TORUN, et al.
Published: (2017-06-01)

Brain Abscess Following Acute Meningitis Associated Chronic Suppurative Otitis Media: Two Case Report
by: Şua SÜMER, et al.
Published: (2014-03-01)

Three Thyroiditis Case Detected While Investigating Fever Etiology
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2018-12-01)

First-wave protease inhibitors for hepatitis C genotype 1 treatment: a real-life experience in Brazilian patients
by: Silvana Gama Florencio Chachá, et al.

Custo-efetividade da Terapia Tripla para pacientes adultos portadores do genótipo 1 da hepatite C crônica.
by: Renata Luzes Araújo
Published: (2015)

Custo-efetividade da Terapia Tripla para pacientes adultos portadores do genótipo 1 da hepatite C crônica.
by: Renata Luzes Araújo
Published: (2015)

The sustained virologic response of nonresponder hepatitis C virus patients with retreatment
by: Sila Cetin Akhan, et al.
Published: (2011-01-01)

Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer
by: Stefania Bartoloni, et al.
Published: (2020-05-01)

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver
by: Norberto C. Chávez-Tapia, et al.
Published: (2013-03-01)

Expressions of obligation, duty, and necessity in Livonian
by: Tiit-Rein Viitso
Published: (2014-07-01)

Intraabdominal Tuberculosis Cases Presenting with Peritoneal Carcinomatosis
by: Nazlım AKTUĞ DEMİR, et al.
Published: (2020-06-01)

The burden of viral hepatitides in the Russian Federation and ways of its reduction for the long term (in case of hepatitis C)
by: N D Iushchuk, et al.
Published: (2013-12-01)

On the cusp of change: New therapeutic modalities for HCV
by: Maribel Rodríguez-Torres
Published: (2010-01-01)